Emily L. Goldberg

Emily L. Goldberg

Auto-generated profile, based on publicly available information

Emily L. Goldberg

University of California, San Francisco

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XZXinbo Zhang
Xinbo Zhang
JMJeffrey G. McDonald
Jeffrey G. McDonald
BABinod Aryal
Binod Aryal
ACAlberto Canfran-Duque
Alberto Canfran-Duque
EGEmily L. Goldberg
Emily L. Goldberg
CFCarlos Fernández
Carlos Fernández
Cholesterol biosynthetic intermediates, such as lanosterol and desmosterol, are emergent immune regulators of macrophages in response to inflammatory stimuli or lipid overloading, respectively. However, the participation of these sterols in regulating macrophage functions in the physiological context of atherosclerosis, an inflammatory disease driven by the accumulation of cholesterol-laden macrophages in the artery wall, has remained elusive. Here, we report that desmosterol, the most abundant cholesterol biosynthetic intermediate in human coronary artery lesions, plays an essential role during atherogenesis, serving as a key molecule integrating cholesterol homeostasis and immune responses in macrophages. Depletion of desmosterol in myeloid cells by overexpression of 3β-hydroxysterol Δ24-reductase (DHCR24), the enzyme that catalyzes conversion of desmosterol to cholesterol, promotes the progression of atherosclerosis. Single-cell transcriptomics in isolated CD45+CD11b+ cells from atherosclerotic plaques demonstrate that depletion of desmosterol increases interferon responses and attenuates the expression of antiinflammatory macrophage markers. Lipidomic and transcriptomic analysis of in vivo macrophage foam cells demonstrate that desmosterol is a major endogenous liver X receptor (LXR) ligand involved in LXR/retinoid X receptor (RXR) activation and thus macrophage foam cell formation. Decreased desmosterol accumulation in mitochondria promotes macrophage mitochondrial reactive oxygen species production and NLR family pyrin domain containing 3 (NLRP3)–dependent inflammasome activation. Deficiency of NLRP3 or apoptosis-associated speck-like protein containing a CARD (ASC) rescues the increased inflammasome activity and atherogenesis observed in desmosterol-depleted macrophages. Altogether, these findings underscore the critical function of desmosterol in the atherosclerotic plaque to dampen inflammation by integrating with macrophage cholesterol metabolism and inflammatory activation and protecting from disease progression. Significance Previous work has shown that foamy macrophages accumulate desmosterol, a cholesterol biosynthetic intermediate. However, the participation of desmosterol in regulating the functions of cholesterol-laden macrophages in the physiological context of atherosclerosis has remained elusive. In this work, we selectively deplete desmosterol by overexpressing DHCR24, the enzyme that catalyzes the conversion of desmosterol into cholesterol, in myeloid cells and demonstrate that desmosterol content in atherosclerotic plaque macrophages controls their function and activation. Molecular analysis of macrophages isolated from lesions revealed that depletion of desmosterol increases the expression of interferon-regulated genes and genes associated with “classical” macrophage activation. Together, our work provides molecular insights into the intimate links between cholesterol metabolism and inflammatory responses of macrophages during atherogenesis.

1 September 2021 in Cell Metabolism
Verified
Journal Article
Closed access
EGEmily L. Goldberg
Emily L. Goldberg
ISIrina Shchukina
Irina Shchukina
YYYun-Hee Youm
Yun-Hee Youm
SRSeungjin Ryu
Seungjin Ryu
TTTakeshi Tsusaka
Takeshi Tsusaka
VDVishwa Deep Dixit
Vishwa Deep Dixit

18 August 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MGMichelangelo B. Gonzatti
Michelangelo B. Gonzatti
JHJordi Hintzen
Jordi Hintzen
ISIsha Sharma
Isha Sharma
MNMohd. Altaf Najar
Mohd. Altaf Najar
TTTakeshi Tsusaka
Takeshi Tsusaka
EGEmily L. Goldberg
Emily L. Goldberg
Metabolism and post-translational modifications (PTMs) are intrinsically linked and the number of identified metabolites that can covalently modify proteins continues to increase. This metabolism/PTM crosstalk is especially true for lactate, the product of anaerobic metabolism following glycolysis. Lactate forms an amide bond with the ε-amino group of lysine, a modification known as lysine lactylation, or Kla. Multiple independent mechanisms have been proposed in the formation of Kla, including p300/CBP-dependent transfer from lactyl-CoA, a reactive intermediate lactoylglutathione species that non-enzymatically lactylates proteins, and several enzymes are reported to have lactyl transferase capability. We recently discovered that class I histone deacetylases (HDACs) 1, 2, and 3 can all reverse their canonical chemical reaction to catalyze lysine β-hydroxybutyrylation. Here we tested the hypothesis that HDACs can also catalyze Kla formation. Using biochemical, pharmacological, and genetic approaches, we found that HDACs are sufficient to catalyze Kla formation and that HDACs are a major driver of lysine lactylation. Dialysis experiments confirm this is a reversible reaction that depends on lactate concentration. We also directly quantified intracellular lactyl-CoA and found that Kla abundance can be uncoupled from lactyl-CoA levels. Therefore, we propose a model in which the majority of Kla is formed through enzymatic addition of lactate by HDACs 1, 2, and 3.

1 December 2020 in Med
Verified
Journal Article
Closed access
BSBrianna J. Stubbs
Brianna J. Stubbs
AKAndrew P. Koutnik
Andrew P. Koutnik
EGEmily L. Goldberg
Emily L. Goldberg
VUVaibhav Upadhyay
Vaibhav Upadhyay
PTPeter James Turnbaugh
Peter James Turnbaugh
JNJohn Newman
John Newman

10 February 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
EGEmily L. Goldberg
Emily L. Goldberg
ALAnudari Letian
Anudari Letian
TDTamara Dlugos
Tamara Dlugos
CLClaire Leveau
Claire Leveau
VDVishwa Deep Dixit
Vishwa Deep Dixit
Aging is accompanied by chronic low-grade inflammation, but the mechanisms that allow this to persist are not well understood. Ketone bodies are alternative fuels produced when glucose is limited and improve indicators of healthspan in aging mouse models. Moreover, the most abundant ketone body, β-hydroxybutyrate, inhibits the NLRP3 inflammasome in myeloid cells, a key potentiator of age-related inflammation. Given that myeloid cells express ketogenic machinery, we hypothesized this pathway may serve as a metabolic checkpoint of inflammation. To test this hypothesis, we conditionally ablated ketogenesis by disrupting expression of the terminal enzyme required for ketogenesis, 3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL). By deleting HMGCL in the liver, we validated the functional targeting and establish that the liver is the only organ that can produce the life-sustaining quantities of ketone bodies required for survival during fasting or ketogenic diet feeding. Conditional ablation of HMGCL in neutrophils and macrophages had modest effects on body weight and glucose tolerance in aging but worsened glucose homeostasis in myeloid cell-specific Hmgcl-deficient mice fed a high-fat diet. Our results suggest that during aging, liver-derived circulating ketone bodies might be more important for deactivating the NLRP3 inflammasome and controlling organismal metabolism.

26 March 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
TTTakeshi Tsusaka
Takeshi Tsusaka
MNMohd. Altaf Najar
Mohd. Altaf Najar
BSBenjamin Schwarz
Benjamin Schwarz
EBEric Bohrnsen
Eric Bohrnsen
JOJuan A Oses-Prieto
Juan A Oses-Prieto
EGEmily L. Goldberg
Emily L. Goldberg